Regulatory guidance for pharmaceutical companies to prepare for UK’s withdrawal from EU:

The European Medicines Agency and the European Commission have published additional guidance to help pharmaceutical companies prepare for the United Kingdom’s withdrawal from the European Union.

Companies are reminded to plan in advance for the situation that the United Kingdom  will leave the EU on 29 March 2019 in order to avoid any impact on the continuous supply of medicines for human and veterinary use within the EU.

To access this guidance go to: